Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ElectroCore, Inc.    ECOR

ELECTROCORE, INC.

(ECOR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/06/2020 07/07/2020 07/08/2020 07/09/2020 07/10/2020 Date
0.825(c) 0.8582(c) 0.8331(c) 0.849(c) 0.85(c) Last
418 051 1 256 825 522 975 551 067 299 334 Volume
+1.85% +4.02% -2.92% +1.91% +0.12% Change
More quotes
Financials (USD)
Sales 2020 4,33 M - -
Net income 2020 -26,5 M - -
Net Debt 2020 - - -
P/E ratio 2020 -1,19x
Yield 2020 -
Sales 2021 10,6 M - -
Net income 2021 -19,7 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,73x
Yield 2021 -
Capitalization 32,4 M 32,4 M -
Capi. / Sales 2020 7,49x
Capi. / Sales 2021 3,07x
Nbr of Employees 51
Free-Float 73,4%
More Financials
Company
ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
07/21 | 11:00amPresentation
More about the company
Surperformance© ratings of electroCore, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ELECTROCORE, INC.
07/09electroCore to Participate in Three Upcoming Virtual Investor Conferences
GL
07/02ELECTROCORE, INC. : Changes in Registrant's Certifying Accountant, Financial Sta..
AQ
06/16ELECTROCORE, INC. : Submission of Matters to a Vote of Security Holders, Other E..
AQ
05/29electroCore, Inc. to Present at Little Grapevine's G1 Microcap Virtual Confer..
GL
05/14ELECTROCORE, INC. : Results of Operations and Financial Condition, Financial Sta..
AQ
05/14electroCore Announces First Quarter Financial Results
GL
05/07electroCore to Announce First Quarter Ended March 31, 2020 Financial Results ..
GL
05/06ELECTROCORE, INC. : Entry into a Material Definitive Agreement, Creation of a Di..
AQ
05/01ELECTROCORE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/27electroCore Provides Update on COVID-19 Clinical Initiatives
GL
04/20ELECTROCORE, INC. : Entry into a Material Definitive Agreement, Results of Opera..
AQ
04/17electroCore Provides Business Update and Select First Quarter 2020 Guidance
GL
04/08electroCore, Inc. Announces Extension of NHS England's Innovation and Technol..
GL
04/02ELECTROCORE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/02electroCore Submits Emergency Use Authorization Application to Allow the Stud..
GL
More news
News in other languages on ELECTROCORE, INC.
07/09electroCore to Participate in Three Upcoming Virtual Investor Conferences
07/02ELECTROCORE, INC. : Changes in Registrant's Certifying Accountant, Financial Sta..
06/16ELECTROCORE, INC. : Submission of Matters to a Vote of Security Holders, Other E..
05/29electroCore, Inc. to Present at Little Grapevine's G1 Microcap Virtual Confer..
05/14ELECTROCORE, INC. : Results of Operations and Financial Condition, Financial Sta..
More news
Chart ELECTROCORE, INC.
Duration : Period :
electroCore, Inc. Technical Analysis Chart | ECOR | US28531P1030 | MarketScreener
Technical analysis trends ELECTROCORE, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 3,50 $
Last Close Price 0,85 $
Spread / Highest target 488%
Spread / Average Target 312%
Spread / Lowest Target 76,5%
EPS Revisions
Managers
NameTitle
Daniel S. Goldberger Chief Executive Officer & Director
Michael G. Atieh Chairman
Michael Romaniw Vice President-Operations, Systems & Logistics
Brian M. Posner Chief Financial Officer & Secretary
Peter S. Staats Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ELECTROCORE, INC.-46.54%32
ABBOTT LABORATORIES7.11%164 573
MASIMO CORPORATION46.23%12 508
ASAHI INTECC CO., LTD.-6.25%7 320
NOVOCURE LIMITED-28.35%6 065
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.95.28%5 682